• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


4.4100 USD 0.1400 3.08%

As of 20:10:00 ET on 01/23/2015.

Company Profile for QLT Inc (QLTI)

QLT Inc. develops and commercializes pharmaceutical products for use in photodynamic therapy, the use of light activated drugs to treat disease. The Company's lead drug, Visudyne, is marketed by Novartis AG, and is used in the treatment of the wet form of age-related macular degeneration.

Contact Information


887 Great Northern Way
Suite 101
Vancouver, BC V5T 4T5
Phone: 1-604-707-7000
Fax: 1-604-707-7001

Key Executives for QLT Inc (QLTI)

Jason M AryehChairmanGeoffrey F Cox "Geoff"Interim CEO
Sukhi JagpalChief Financial OfficerGlen IbbottVP:Finance

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil